An underground market for unlicensed slimming medications is being driven by TikTok fitness influencers and sellers on communication apps, based on recent findings.
Experimental Drug Acquiring Popularity Via Social Media
Retatrutide, which is still in research studies, is being promoted by social media influencers for its supposed fat-burning properties. Followers are encouraged to contact these profiles directly for supplier links, while also receiving discount codes.
Thriving Commerce on Messaging Platforms
Separately, a robust trade exists on messaging services, where groups with numerous of members share comparison photos, injection guides and claims of rapid UK delivery. Sellers promote the drug there before directing buyers to other platforms for transactions.
Learning About The Experimental Drug
Retatrutide is an investigational injectable created by US drugmaker Eli Lilly. The treatment affects three intestinal hormones – GLP-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Early trials suggest it could assist individuals lose up to 25% of their body weight. Nicknamed the “triple G”, the drug is being promoted online as the next Ozempic.
Medical Experts Voice Worries
However, physicians and chemists have warned that the sale of what remains an unlicensed drug in the United Kingdom is a cause for concern and could lead to individuals administering products of unknown origin.
Several experts said the demand for retatrutide could be linked to the increasing price of approved weight loss products such as Mounjaro.
Regulatory Status and Implementation
Marketing retatrutide on TikTok or Telegram is prohibited in the United Kingdom, as it is an unapproved medication that cannot be promoted or supplied for personal consumption under the British medical regulations.
Some content creators attempt to sidestep the regulations by calling to the substance as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a restricted substance, but advertising and supply can still breach pharmaceutical, advertising, and consumer regulations, potentially leading to fines, prosecution or prison.
Service Response and Material Elimination
According to TikTok, the platform has taken down problematic material and banned related keywords and search suggestions. The organization stated it was committed to keeping the service safe and allocating resources in strengthening enforcement strategies.
Digital Marketplace Operations
Research also discovered groups with up to 9,000 participants selling retatrutide using the platform's integrated discovery tool, which operates like a public directory. Entering “retatrutide” instantly displays groups with thousands of users, filled with photos of weight loss, glowing testimonials and step-by-step guides for mixing or administering at home.
Within minutes of joining one group, a vendor shared WhatsApp details, where most purchases occur. The seller sent an guidebook and promised shipping within 48 hours. When questioned whether the product was genuine, one vendor said: “You can’t be sure.” Another provided a image of a supposed laboratory certificate. None inquired about weight, health issues or past usage.
Product Information and Pricing
Within these groups, messages show black plastic parcels with Royal Mail labels, claiming to contain new batches. One communication stated: “It took eight of us to load them this morning.”
Customers can choose between dry substance containers, mixed at residence with purified liquid, or pre-filled injectors usually priced at 160 pounds for 20 milligrams. When asked how long a pen should be used, sellers give conflicting answers varying between a few weeks to “depends on your body”.
Platform Moderation and Safety Actions
A representative for the messaging service said it actively monitored harmful material on its platform including material that encouraged the “misuse of controlled medications”. The organization noted that it eliminated “millions of pieces of harmful content each day”.
Healthcare Professional Cautions
“Individuals are administering materials they cannot confirm. Even if the science behind this drug is valid, these digital versions may not contain what they claim,” said Jason Murphy, the director of pharmacy at Chemist4U.
A medical professional of Asda Online Doctor linked the increase in demand to current price rises for authorized weight-loss drugs such as Mounjaro. “With prices rising, individuals are using online platforms. But fake injections are highly risky. You can’t be certain what’s contained or whether the environment they were produced in was sterile,” she said.
Her staff has already seen individuals injured by personal administration from unconfirmed suppliers. “We understand the disappointment, but purchasing from Telegram or communication platforms is gambling with your well-being,” stated Wyllie. “These substances could be contaminated or incorrectly dosed.”
Manufacturer Position
A representative from Eli Lilly said retatrutide was in phase 3 clinical trials and had not been reviewed or approved by any regulatory agency anywhere in the world. “Consequently at this point no one can market [it] for human use,” they said, noting that any item “misleadingly claiming itself as a company investigational product not yet authorized … may subject patients to possibly significant health risks”.
